New PET tracers targeting PD-L1 for head and neck cancer and glypican-3 for early hepatocellular carcinoma detection have shown enhanced specificity and imaging clarity. Concurrently, novel radiotracers demonstrate broad sensitivity to invasive mold infections in immunocompromised patients, offering rapid noninvasive diagnostics that may improve clinical outcomes.